These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 16312606

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Vancomycin and teicoplanin: differential aspects].
    Cobo J.
    Enferm Infecc Microbiol Clin; 1995 Dec; 13(10):600-10. PubMed ID: 8808477
    [No Abstract] [Full Text] [Related]

  • 3. [The use of teicoplanin for Gram-positive infections in patients with kidney transplantation].
    Jákics J, Gálffy Z, Hernold L, Rácz A, Perner F.
    Orv Hetil; 1996 Jun 23; 137(25):1355-8. PubMed ID: 8757082
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Role of teicoplanin in the ambulatory treatment of infections in children due to gram-positive microorganisms].
    Debbag R, Paganini H, Gómez S, Casimir L, Stamboulian D.
    Medicina (B Aires); 2002 Jun 23; 62 Suppl 2():48-51. PubMed ID: 12481489
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Recommendations to achieve rapid therapeutic teicoplanin plasma concentrations in adult hospitalised patients treated for sepsis.
    Brink AJ, Richards GA, Cummins RR, Lambson J, Gauteng Understanding Teicoplanin Serum levels (GUTS) study group.
    Int J Antimicrob Agents; 2008 Nov 23; 32(5):455-8. PubMed ID: 18718742
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ambulatory treatment with intramuscular ceftriaxone.
    Schlaeffer F.
    J Chemother; 1989 Jul 23; 1(4 Suppl):655-6. PubMed ID: 16312577
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dalbavancin: a new option for the treatment of gram-positive infections.
    Lin SW, Carver PL, DePestel DD.
    Ann Pharmacother; 2006 Mar 23; 40(3):449-60. PubMed ID: 16507624
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness of the antibiotic lock therapy for the treatment of port-related enterococci, Gram-negative, or Gram-positive bacilli bloodstream infections.
    Del Pozo JL, Alonso M, Serrera A, Hernaez S, Aguinaga A, Leiva J.
    Diagn Microbiol Infect Dis; 2009 Feb 23; 63(2):208-12. PubMed ID: 19026506
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Establishing the role of tigecycline in an era of antimicrobial resistance.
    Schafer JJ, Goff DA.
    Expert Rev Anti Infect Ther; 2008 Oct 23; 6(5):557-67. PubMed ID: 18847395
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [First case of infection due to vancomycin resistant Enterococcus faecalis in New Caledonia].
    Garin B, Barny S, Lechevallier S, Agathe-Nerine J.
    Med Mal Infect; 2006 May 23; 36(5):297-8. PubMed ID: 16631333
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.